HBV 的变异及其耐药的诊治

2011.12.28HBV 的变异及其耐药的诊治

HBV 的变异及其耐药的诊治-1变异是病毒重要生物学特征之一-2变异株 ≠ 突变株-3病毒感染的持久性及耐药性-4耐药分析-5Lamivudine and wild-type HBV(一)-6Lamivudine and wild-type HBV(二)-7Lamivudine and YM ...

HBV, HCV/HIV Coinfection

2011.12.28HBV, HCV/HIV Coinfection

HBV HCV HIV Coinfection-1Epidemiology-2Liver disease a major cause of death in the HAART era-3Routes of Transmission-4Transmissibility through contaminated in ...

Hepatitis B and Hepatitis B Vaccine

2011.12.28Hepatitis B and Hepatitis B Vaccine

Hepatitis B and Hepatitis B Vaccine-1Note to presenters-2Hepatitis B-3Hepatitis B Virus-4Hepatitis B Virus Infection-5Hepatitis B Virus-6Hepatitis B Clinical F ...

Hepatitis B Viruss Discovery and Development

2011.12.28Hepatitis B Viruss Discovery and Development

HEPATITIS B VIRUS-1HEPATITIS B VIRUS-2HEPATITIS B VIRUS MORPHOLOGY-3HEPATITIS B VIRUS MORPHOLOGY-4the hunt of a killer virus-5global distribution of chronic inf ...

Hepatitis B what GI nurses Need to Know

2011.12.28Hepatitis B what GI nurses Need to Know

Hepatitis B- what GI nurses Need to Know-1Hepatitis B-2Hepatitis B -3Global Impact of Hepatitis B-4hepatitis B virus-5Korean Mummy Found With HBV-6geographic prevale ...

NEW INSIGHTS INTO TREATMENT OF HEPATITIS B

2011.12.28NEW INSIGHTS INTO TREATMENT OF HEPATITIS B

NEW INSIGHTS INTO TREATMENT OF HEPATITIS B-1Disclosures-2geographic distribution-3Chronic Hepatitis B in Asia-Pacific-4hepatitis b case rates-5Chronic He ...

ofile, grading & investigations in hepatitis B

2011.12.28ofile, grading & investigations in hepatitis B

Kar:clinical profile grading investigations in hepatitis B-1Kar:clinical profile grading investigations in hepatitis B-2Kar:clinical profile grading and i ...

抗HBV特异性主动免疫疗法

2011.12.28抗HBV特异性主动免疫疗法

抗HBV特异性主动免疫疗法-1治疗对象-2病例入选条件-3病例入选条件-4终止疗法条件-5终止疗法条件-6不能入选的条件-7治疗方法 -8治疗方法 -9终止治疗条件-10终止治疗条件-11治疗方法-12单一抗HBV特异性主动免疫疗法-13单一疗法适应症-14联 ...

重庆啤酒乙肝疫苗II期临床揭盲 疫苗组与安慰剂组无显著性差异

2011.12.08重庆啤酒乙肝疫苗II期临床揭盲 疫苗组与安慰剂组无显著性差异

一再拖延之后,重庆啤酒在7日晚间发布关于乙肝疫苗二期临床数据揭盲情况的相关公告。数据显示,重庆啤酒研发13年的治疗用乙肝疫苗疗效远低于市场预期。分析师认为,这将严重动摇重庆啤酒的估值基础,首当其冲的,恐怕就是重仓重庆啤酒的大成基金。重庆啤酒这份《关于 ...

2011.12.08重庆啤酒股份有限公司董事会关于“治疗用(合成肽)乙型肝炎疫苗”研究进度暨复牌公告

重庆啤酒股份有限公司董事会关于“治疗用(合成肽)乙型肝炎疫苗”研究进度暨复牌公告本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。特别提示:1、 ...

上一页 1 2 3 ... 33 34 35 ... 40 41 42 下一页 到第
  • App下载